Dilip Shanghvi, 64, is the Managing Director of world’s 4th largest and India’s top specialty generic pharmaceutical company, Sun Pharmaceutical Industries Ltd. Mr. Shanghvi is also Chairman and Managing Director of Sun Pharma Advanced Research Company Ltd. which is engaged in R&D of new innovative drugs and delivery systems. He is a former President of Indian Pharmaceutical Alliance. Mr. Shanghvi has been conferred with many awards and recognitions including, Padma Shri (Fourth highest civilian award by Govt. of India) in 2016, Forbes Entrepreneur for the year – 2014, Economic Times’ Business Leader of the Year (2014), CNN IBN’s Indian of the Year (Business) (2011), Business India’s Businessman of the Year (2011) and Ernst and Young’s World Entrepreneur of the Year (2011). He has also been awarded the Economic Times’ Entrepreneur of the Year (2008), Business Standard’s CEO of the Year (2008) and CNBC TV 18’s First Generation Entrepreneur of the Year (2007).
In 2017, he was made a trustee of the Rhodes Scholarship Program at Oxford University. In January 2018, the Indian government appointed Mr. Shanghvi to the Reserve Bank of India’s 21-member central board committee. He is also chairman of the board of governors at Indian Institute of Technology (Bombay). In 2019, Mr. Shanghvi was conferred with an honorary doctorate by the Tel Aviv University, Israel’s largest and most comprehensive institution of higher learning.
Subscribe to our blogs
Get alerts for latest posts